Facebook
Twitter
Telegram
Report an ErrorSio Gene Therapies Financial Ratios 2011-2024 | SIOX
Annual Financial Ratios Sio Gene Therapies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | - | - | - | - | - | - | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - |
EPS |
-0.6 | -2.9 | -8.0 | -2.1 | -1.8 | -1.4 | - | - | - | - | - |
EV (Enterprise Value) |
-107 M | -48.6 M | -40.5 M | -64.8 M | -115 M | -260 M | 8.87 M | - | - | - | - |
EBITDA per Share |
-0.607 | - | - | - | - | - | - | - | - | - | - |
EV/EBITDA |
3.4 | - | - | - | - | - | - | - | - | - | - |
PEG |
- | - | - | - | - | - | - | - | - | - | - |
P/B |
- | - | - | - | - | - | - | - | - | - | - |
P/CF |
- | - | - | - | - | - | - | - | - | - | - |
ROE % |
-2.70 | - | - | - | - | - | - | - | - | - | - |
ROA % |
-2.46 | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-26.46 | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
11.5 | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Sio Gene Therapies
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.05 | -0.21 | -0.16 | -0.18 | -0.35 | -0.8 | -0.45 | -0.16 | -0.2 | -0.21 | -0.2 | -0.2 | -0.62 | -0.62 | -1.23 | -1.23 | -2.13 | -0.27 | -0.28 | -1.88 | -4.3 | -5.14 | -5.21 | -0.65 | -0.48 | -0.48 | -0.43 | -0.38 | -0.64 | -0.64 | -0.15 | -0.31 | -1.08 | -1.08 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.05 | -0.21 | -0.15 | - | -0.35 | -0.8 | -0.45 | - | -0.2 | -0.21 | -0.22 | -0.2 | -0.62 | -0.56 | -1.21 | -1.21 | -2.13 | -0.25 | -0.27 | - | -0.54 | -0.66 | -0.62 | - | -0.48 | -1.28 | -0.8 | - | -0.63 | -1.1 | -0.45 | - | -1.08 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-78.92 | -103.39 | -130.63 | -124.87 | -113.27 | -91.71 | -44.58 | -48.43 | -52.62 | -318.98 | -585.33 | -666.59 | -747.51 | -620.03 | -492.55 | -567.16 | -507.09 | -410.70 | -305.12 | -168.50 | -188.47 | -162.90 | -141.01 | -125.01 | -83.79 | -77.07 | -74.14 | -61.27 | 274.93 | 483.71 | 503.99 | 508.71 | 186.78 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-68.55 | -87.33 | -111.46 | -107.76 | -98.79 | -82.14 | -42.34 | -46.65 | -47.04 | -69.63 | -74.90 | -88.51 | -102.20 | -104.62 | -119.73 | -123.52 | -116.40 | -110.25 | -104.75 | -95.72 | -111.10 | -104.81 | -97.12 | -91.14 | -73.48 | -71.13 | -70.38 | -58.53 | -2278.99 | -2258.14 | -2238.51 | -2233.93 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-96.18 | -120.66 | -147.92 | -121.59 | -133.62 | -112.26 | -65.31 | -38.59 | -53.20 | -319.53 | -585.85 | -666.76 | -747.60 | -619.72 | -491.83 | -566.10 | -524.92 | -428.73 | -324.41 | -132.78 | -161.60 | -136.15 | -151.87 | -123.74 | -145.46 | -138.37 | -109.35 | -67.01 | 119.77 | 328.27 | 361.11 | 186.78 | 186.78 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
22.0 | 11.1 | 5.8 | 5.1 | 5.5 | 9.9 | 14.3 | 11.5 | 10.0 | 7.9 | 5.7 | 2.9 | 1.1 | 1.3 | 1.4 | 1.9 | 1.3 | 1.2 | 1.3 | 1.8 | 2.2 | 2.6 | 3.0 | 2.3 | 5.2 | 8.2 | 15.2 | 17.9 | 19.1 | 31.1 | 34.6 | 0.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency